Reading TNDM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track TNDM free→Reading TNDM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track TNDM free→QuarterlyIQ Insights · TNDM
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
The filing describes a stockholder-approved amendment to the Long-Term Incentive Plan.
Material Modification to Rights of Security Holders. On May 20, 2026, at the 2026 Annual Meeting of Stockholders (the Annual Meeting) of Tandem Diabetes Care, Inc. (the Company), upon recommendation of the Company’s Board of Directors (the Board), the Company’s stockholders approved amendments to the Company’s Amended and Restated Certificate of Incorporation to: (i) provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law (…
Executive Vice President and Chief Commercial Officer — Mark Novara: Mr. Novara's employment was terminated without cause.
and Exhibit 99.1 hereto is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Importance-ranked changes since the prior daily snapshot.
Signal changed from 'mixed' to 'mild_favorable'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.